Centiva Capital, LP Insulet Corp Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $2 Million - $2.55 Million	12,211 New	12,211 $2.09 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $2.5 Million - $4.7 Million	16,173 New	16,173 $2.58 Million
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $254,622 - $381,141	-1,366 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$194.8 - $275.7 $266,096 - $376,606	1,366 New	1,366 $364,000
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $333,447 - $415,686	-1,306 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$260.36 - $307.27 $340,030 - $401,294	1,306 New	1,306 $371,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.